Relapsed or refractory central nervous system lymphoma successfully treated by glofitamab combined with lenalidomide
The glofitamab-lenalidomide combination showed promising activity and excellent tolerability in R/R CNSL, potentially addressing the critical need for effective salvage regimens.
Authors
- Xiaoqiong Tang (ORCID: https://orcid.org/0000-0002-6018-736X)
- Yin-yin Peng (ORCID: https://orcid.org/0000-0001-9636-0577)
Institutions
- The Affiliated Yongchuan Hospital of Chongqing Medical University (CN)
- Chongqing Medical University (CN)
Publication Details
- Journal
- Frontiers in Oncology
- Published
- 2025-11-03
- DOI
- https://doi.org/10.3389/fonc.2025.1685271
- Citations
- 1
- Primary Topic
- Protein Degradation and Inhibitors
- Type
- article
- Field-Weighted Citation Impact
- 0.81